Serveur d'exploration sur Pittsburgh

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS.

Identifieur interne : 000250 ( Main/Exploration ); précédent : 000249; suivant : 000251

Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS.

Auteurs : Thorhildur Halldorsdottir ; Thomas H. Ollendick ; Golda Ginsburg ; Joel Sherrill ; Philip C. Kendall ; John Walkup ; Dara J. Sakolsky [États-Unis] ; John Piacentini

Source :

RBID : pubmed:25310142

Descripteurs français

English descriptors

Abstract

The purpose of this study is to examine the influence of Attention-Deficit/Hyperactivity Disorder (ADHD), independent of Oppositional Defiant Disorder (ODD), on acute treatment response, remission rates and maintenance of gains at 6-month follow-up in anxious youth (ages 7-17, 76% Caucasian, 52% female) who received cognitive-behavioral therapy (CBT) alone, pharmacotherapy alone, the combination of CBT and pharmacotherapy or placebo pill in the Child/Adolescent Multimodal Study. Treatment response was defined as independent evaluator rated meaningful improvement in anxiety. Remission was operationalized as the absence of targeted anxiety disorders. ADHD and ODD were examined as moderators of outcomes at a diagnostic level. In the CBT group only, an ADHD diagnosis predicted poorer immediate treatment response and remission rates. However, these associations were not obtained for the pharmacotherapy groups. Participants with comorbid ODD were not less likely to achieve acute treatment response and remission rates than their counterparts across treatment conditions. Due to small sample size of the comorbid subgroups, our analyses must be considered preliminary. Nevertheless, our initial findings suggest further exploration of the separate roles of ADHD and ODD are worth pursuing, as they may be differentially associated with treatment outcomes in anxious youth treated with CBT but not youth treated with pharmacotherapy. If confirmed, findings may indicate that anxious youth with comorbid ADHD are less likely to benefit from CBT strategies alone and raise the possibility that these youth need adjunctive pharmacotherapy or psychosocial interventions.

DOI: 10.1080/15374416.2014.952008
PubMed: 25310142


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS.</title>
<author>
<name sortKey="Halldorsdottir, Thorhildur" sort="Halldorsdottir, Thorhildur" uniqKey="Halldorsdottir T" first="Thorhildur" last="Halldorsdottir">Thorhildur Halldorsdottir</name>
<affiliation>
<nlm:affiliation>a Department of Psychology , Virginia Polytechnic Institute and State University.</nlm:affiliation>
<wicri:noCountry code="subField">Virginia Polytechnic Institute and State University</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Ollendick, Thomas H" sort="Ollendick, Thomas H" uniqKey="Ollendick T" first="Thomas H" last="Ollendick">Thomas H. Ollendick</name>
<affiliation>
<nlm:affiliation>a Department of Psychology , Virginia Polytechnic Institute and State University.</nlm:affiliation>
<wicri:noCountry code="subField">Virginia Polytechnic Institute and State University</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Ginsburg, Golda" sort="Ginsburg, Golda" uniqKey="Ginsburg G" first="Golda" last="Ginsburg">Golda Ginsburg</name>
<affiliation>
<nlm:affiliation>b Division of Child and Adolescent Psychiatry, John Hopkins University School of Medicine.</nlm:affiliation>
<wicri:noCountry code="subField">John Hopkins University School of Medicine</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Sherrill, Joel" sort="Sherrill, Joel" uniqKey="Sherrill J" first="Joel" last="Sherrill">Joel Sherrill</name>
<affiliation>
<nlm:affiliation>c Division of Services and Intervention Research, National Institute of Mental Health.</nlm:affiliation>
<wicri:noCountry code="subField">National Institute of Mental Health</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kendall, Philip C" sort="Kendall, Philip C" uniqKey="Kendall P" first="Philip C" last="Kendall">Philip C. Kendall</name>
<affiliation>
<nlm:affiliation>d Department of Psychology , Temple University.</nlm:affiliation>
<wicri:noCountry code="subField">Temple University</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Walkup, John" sort="Walkup, John" uniqKey="Walkup J" first="John" last="Walkup">John Walkup</name>
<affiliation>
<nlm:affiliation>e Department of Psychiatry , Weill Cornell Medical College and New York-Presbyterian Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Weill Cornell Medical College and New York-Presbyterian Hospital</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Sakolsky, Dara J" sort="Sakolsky, Dara J" uniqKey="Sakolsky D" first="Dara J" last="Sakolsky">Dara J. Sakolsky</name>
<affiliation wicri:level="4">
<nlm:affiliation>f Department of Psychiatry , University of Pittsburgh.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
<author>
<name sortKey="Piacentini, John" sort="Piacentini, John" uniqKey="Piacentini J" first="John" last="Piacentini">John Piacentini</name>
<affiliation>
<nlm:affiliation>g UCLA Psychiatry and Behavioral Science, Semel Institute.</nlm:affiliation>
<wicri:noCountry code="subField">Semel Institute</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25310142</idno>
<idno type="pmid">25310142</idno>
<idno type="doi">10.1080/15374416.2014.952008</idno>
<idno type="wicri:Area/PubMed/Corpus">000A45</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000A45</idno>
<idno type="wicri:Area/PubMed/Curation">000A45</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000A45</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000A45</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000A45</idno>
<idno type="wicri:Area/Ncbi/Merge">003A11</idno>
<idno type="wicri:Area/Ncbi/Curation">003A11</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003A11</idno>
<idno type="wicri:Area/Main/Merge">000250</idno>
<idno type="wicri:Area/Main/Curation">000250</idno>
<idno type="wicri:Area/Main/Exploration">000250</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS.</title>
<author>
<name sortKey="Halldorsdottir, Thorhildur" sort="Halldorsdottir, Thorhildur" uniqKey="Halldorsdottir T" first="Thorhildur" last="Halldorsdottir">Thorhildur Halldorsdottir</name>
<affiliation>
<nlm:affiliation>a Department of Psychology , Virginia Polytechnic Institute and State University.</nlm:affiliation>
<wicri:noCountry code="subField">Virginia Polytechnic Institute and State University</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Ollendick, Thomas H" sort="Ollendick, Thomas H" uniqKey="Ollendick T" first="Thomas H" last="Ollendick">Thomas H. Ollendick</name>
<affiliation>
<nlm:affiliation>a Department of Psychology , Virginia Polytechnic Institute and State University.</nlm:affiliation>
<wicri:noCountry code="subField">Virginia Polytechnic Institute and State University</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Ginsburg, Golda" sort="Ginsburg, Golda" uniqKey="Ginsburg G" first="Golda" last="Ginsburg">Golda Ginsburg</name>
<affiliation>
<nlm:affiliation>b Division of Child and Adolescent Psychiatry, John Hopkins University School of Medicine.</nlm:affiliation>
<wicri:noCountry code="subField">John Hopkins University School of Medicine</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Sherrill, Joel" sort="Sherrill, Joel" uniqKey="Sherrill J" first="Joel" last="Sherrill">Joel Sherrill</name>
<affiliation>
<nlm:affiliation>c Division of Services and Intervention Research, National Institute of Mental Health.</nlm:affiliation>
<wicri:noCountry code="subField">National Institute of Mental Health</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Kendall, Philip C" sort="Kendall, Philip C" uniqKey="Kendall P" first="Philip C" last="Kendall">Philip C. Kendall</name>
<affiliation>
<nlm:affiliation>d Department of Psychology , Temple University.</nlm:affiliation>
<wicri:noCountry code="subField">Temple University</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Walkup, John" sort="Walkup, John" uniqKey="Walkup J" first="John" last="Walkup">John Walkup</name>
<affiliation>
<nlm:affiliation>e Department of Psychiatry , Weill Cornell Medical College and New York-Presbyterian Hospital.</nlm:affiliation>
<wicri:noCountry code="subField">Weill Cornell Medical College and New York-Presbyterian Hospital</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Sakolsky, Dara J" sort="Sakolsky, Dara J" uniqKey="Sakolsky D" first="Dara J" last="Sakolsky">Dara J. Sakolsky</name>
<affiliation wicri:level="4">
<nlm:affiliation>f Department of Psychiatry , University of Pittsburgh.</nlm:affiliation>
<country>États-Unis</country>
<placeName>
<settlement type="city">Pittsburgh</settlement>
<region type="state">Pennsylvanie</region>
</placeName>
<orgName type="university">Université de Pittsburgh</orgName>
</affiliation>
</author>
<author>
<name sortKey="Piacentini, John" sort="Piacentini, John" uniqKey="Piacentini J" first="John" last="Piacentini">John Piacentini</name>
<affiliation>
<nlm:affiliation>g UCLA Psychiatry and Behavioral Science, Semel Institute.</nlm:affiliation>
<wicri:noCountry code="subField">Semel Institute</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53</title>
<idno type="eISSN">1537-4424</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Anxiety Disorders (drug therapy)</term>
<term>Anxiety Disorders (psychology)</term>
<term>Attention Deficit Disorder with Hyperactivity (epidemiology)</term>
<term>Attention Deficit Disorder with Hyperactivity (psychology)</term>
<term>Attention Deficit Disorder with Hyperactivity (therapy)</term>
<term>Attention Deficit and Disruptive Behavior Disorders (epidemiology)</term>
<term>Attention Deficit and Disruptive Behavior Disorders (therapy)</term>
<term>Case-Control Studies</term>
<term>Child</term>
<term>Cognitive Therapy (methods)</term>
<term>Comorbidity</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Serotonin Uptake Inhibitors (administration & dosage)</term>
<term>Serotonin Uptake Inhibitors (pharmacology)</term>
<term>Sertraline (administration & dosage)</term>
<term>Sertraline (pharmacology)</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Comorbidité</term>
<term>Enfant</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Inhibiteurs de la capture de la sérotonine (administration et posologie)</term>
<term>Inhibiteurs de la capture de la sérotonine (pharmacologie)</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Sertraline (administration et posologie)</term>
<term>Sertraline (pharmacologie)</term>
<term>Thérapie cognitive ()</term>
<term>Trouble déficitaire de l'attention avec hyperactivité ()</term>
<term>Trouble déficitaire de l'attention avec hyperactivité (psychologie)</term>
<term>Trouble déficitaire de l'attention avec hyperactivité (épidémiologie)</term>
<term>Troubles anxieux (psychologie)</term>
<term>Troubles anxieux (traitement médicamenteux)</term>
<term>Troubles déficitaires de l'attention et du comportement perturbateur ()</term>
<term>Troubles déficitaires de l'attention et du comportement perturbateur (épidémiologie)</term>
<term>Études cas-témoins</term>
<term>Études de suivi</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Serotonin Uptake Inhibitors</term>
<term>Sertraline</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Inhibiteurs de la capture de la sérotonine</term>
<term>Sertraline</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Anxiety Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Attention Deficit Disorder with Hyperactivity</term>
<term>Attention Deficit and Disruptive Behavior Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Cognitive Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Inhibiteurs de la capture de la sérotonine</term>
<term>Sertraline</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Serotonin Uptake Inhibitors</term>
<term>Sertraline</term>
</keywords>
<keywords scheme="MESH" qualifier="psychologie" xml:lang="fr">
<term>Trouble déficitaire de l'attention avec hyperactivité</term>
<term>Troubles anxieux</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Anxiety Disorders</term>
<term>Attention Deficit Disorder with Hyperactivity</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Attention Deficit Disorder with Hyperactivity</term>
<term>Attention Deficit and Disruptive Behavior Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Troubles anxieux</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Trouble déficitaire de l'attention avec hyperactivité</term>
<term>Troubles déficitaires de l'attention et du comportement perturbateur</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Case-Control Studies</term>
<term>Child</term>
<term>Comorbidity</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Comorbidité</term>
<term>Enfant</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Résultat thérapeutique</term>
<term>Thérapie cognitive</term>
<term>Trouble déficitaire de l'attention avec hyperactivité</term>
<term>Troubles déficitaires de l'attention et du comportement perturbateur</term>
<term>Études cas-témoins</term>
<term>Études de suivi</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The purpose of this study is to examine the influence of Attention-Deficit/Hyperactivity Disorder (ADHD), independent of Oppositional Defiant Disorder (ODD), on acute treatment response, remission rates and maintenance of gains at 6-month follow-up in anxious youth (ages 7-17, 76% Caucasian, 52% female) who received cognitive-behavioral therapy (CBT) alone, pharmacotherapy alone, the combination of CBT and pharmacotherapy or placebo pill in the Child/Adolescent Multimodal Study. Treatment response was defined as independent evaluator rated meaningful improvement in anxiety. Remission was operationalized as the absence of targeted anxiety disorders. ADHD and ODD were examined as moderators of outcomes at a diagnostic level. In the CBT group only, an ADHD diagnosis predicted poorer immediate treatment response and remission rates. However, these associations were not obtained for the pharmacotherapy groups. Participants with comorbid ODD were not less likely to achieve acute treatment response and remission rates than their counterparts across treatment conditions. Due to small sample size of the comorbid subgroups, our analyses must be considered preliminary. Nevertheless, our initial findings suggest further exploration of the separate roles of ADHD and ODD are worth pursuing, as they may be differentially associated with treatment outcomes in anxious youth treated with CBT but not youth treated with pharmacotherapy. If confirmed, findings may indicate that anxious youth with comorbid ADHD are less likely to benefit from CBT strategies alone and raise the possibility that these youth need adjunctive pharmacotherapy or psychosocial interventions.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Pennsylvanie</li>
</region>
<settlement>
<li>Pittsburgh</li>
</settlement>
<orgName>
<li>Université de Pittsburgh</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Ginsburg, Golda" sort="Ginsburg, Golda" uniqKey="Ginsburg G" first="Golda" last="Ginsburg">Golda Ginsburg</name>
<name sortKey="Halldorsdottir, Thorhildur" sort="Halldorsdottir, Thorhildur" uniqKey="Halldorsdottir T" first="Thorhildur" last="Halldorsdottir">Thorhildur Halldorsdottir</name>
<name sortKey="Kendall, Philip C" sort="Kendall, Philip C" uniqKey="Kendall P" first="Philip C" last="Kendall">Philip C. Kendall</name>
<name sortKey="Ollendick, Thomas H" sort="Ollendick, Thomas H" uniqKey="Ollendick T" first="Thomas H" last="Ollendick">Thomas H. Ollendick</name>
<name sortKey="Piacentini, John" sort="Piacentini, John" uniqKey="Piacentini J" first="John" last="Piacentini">John Piacentini</name>
<name sortKey="Sherrill, Joel" sort="Sherrill, Joel" uniqKey="Sherrill J" first="Joel" last="Sherrill">Joel Sherrill</name>
<name sortKey="Walkup, John" sort="Walkup, John" uniqKey="Walkup J" first="John" last="Walkup">John Walkup</name>
</noCountry>
<country name="États-Unis">
<region name="Pennsylvanie">
<name sortKey="Sakolsky, Dara J" sort="Sakolsky, Dara J" uniqKey="Sakolsky D" first="Dara J" last="Sakolsky">Dara J. Sakolsky</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000250 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000250 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25310142
   |texte=   Treatment Outcomes in Anxious Youth with and without Comorbid ADHD in the CAMS.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25310142" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PittsburghV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021